BioSpace News Archive

Company’s RT-PCR kits and workflow solutions will continue to safeguard capacity for NHS Test and Trace laboratory

Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in a fireside chat during the Jefferies Virtual Healthcare Conference.

Leaps by Bayer, the impact investment arm of Bayer AG, today announces that it has led a USD 90 million Series B investment in Berlin-based digital health company Ada Health GmbH (“Ada”). Additional investors joined the round, including Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures.

-- FDA Advisory Committee to Review Biologics License Application for PRV-031 for the Delay of Clinical Type 1 Diabetes --

CollPlant, a regenerative and aesthetic medicine company, announced financial results for the first quarter ended March 31, 2021 and provided an update on the Company’s business developments.

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced it has entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISAV B [Hepatitis B Vaccine (Recombinant), Adjuvanted] in Germany

Leading authority on infectious disease, Dr. Bradley Perkins, to accelerate clinical evidence of the Karius Test™, a liquid biopsy for infectious disease

Aker BioMarine, the global biotech innovator and world-leading supplier of krill, announces the appointment of biotechnology and pharmaceutical executive Douglas C. Hicks to the position of Senior Vice President – Business Development and Strategy, to lead Aker BioMarine’s entry into the pharmaceutical segment.

Latest release of Tetra Data Platform fully automates the round trip communication between instruments and ELN/LIMS systems for global pharmaceutical and biotech organizations

Konica Minolta Precision Medicine (KMPM), announced today that Tom Schoenherr , Chief Executive Officer of Ambry Genetics, a KMPM company, will present at the third annual AWS Healthcare & Life Science Virtual Symposium on Thursday, May 27, 2021